Effectiveness Of Octreotide In The Treatment Of Patients With Acute Pancreatitis: An Observational Study
No Thumbnail Available
Date
2025-06
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Indian Society for Health and Advanced Research
Abstract
Acute pancreatitis (AP) is an inflammatory condition of the pancreas having high morbidity and mortality, often leading to complications. Octreotide, a synthetic analogue of somatostatin, has been studied for its potential benefits in mitigating pancreatic inflammation and improving clinical outcomes. This observational study evaluates the effectiveness of octreotide in managing AP by analyzing clinical parameters such as pain relief, bowel motility, and complication rates. Conducted at a tertiary care hospital, the study included 50 patients divided into two groups—one receiving standard care with octreotide and the other receiving standard care alone. Results demonstrated that octreotide administration significantly reduced pain scores, enhanced bowel motility, and lowered complication rates. However, larger randomized controlled trials are recommended to establish definitive treatment guidelines.
Description
Keywords
Citation
Kele Vivek, Suraj Lisha. Effectiveness Of Octreotide In The Treatment Of Patients With Acute Pancreatitis: An Observational Study. International Journal of Scientific Research. 2025 Jun; 14(6): 19-20